Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2005
05/31/2005US6900198 Salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide
05/31/2005US6900197 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
05/31/2005US6900195 Administering to a subject an effective amount of a manzamine, manzamine derivative or analog or isomer to treat bacterial, parasitic, viral and other infections
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/31/2005US6900191 Anticancer agents
05/31/2005US6900189 Analgesic and glucosamine compositions
05/31/2005US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
05/31/2005US6900183 Macrolide antibiotics
05/31/2005US6900182 Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury
05/31/2005US6900181 Wound healing agents; antiscarring agents; using mannose-6-phosphonate
05/31/2005US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders
05/31/2005US6900179 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
05/31/2005US6900175 Administering teichoplanin
05/31/2005US6900173 Mixture containing digestion enzyme, vitamins, amino acid
05/31/2005US6900161 Azole or triazole derivatives, method for preparing same and use thereof as fungicides
05/31/2005US6900160 Triazolo-epothilones
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
05/31/2005US6900008 Methods and formulations for minimizing spasticity in blood vessel grafts
05/31/2005US6899901 Cooling or heating sensitizers such as oleoresin or spilanthol, for use in foods, drugs or cosmetics
05/31/2005US6899900 Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
05/31/2005US6899898 Induced phase transition method for the production of microparticles containing hydrophobic active agents
05/31/2005US6899897 Comprises benzoin gum, fungicidal clotrimazole, and ethanol; for treatment of athelete's foot, eczema, seborrheic dermatitis and psoriasis
05/31/2005US6899896 Hydrogel-driven layered drug dosage form
05/31/2005US6899894 Mixture of oestradiol and norethisterone acetate applied to backing with pressure sensitive adhesive; protective coatings; multilayer
05/31/2005US6899893 Method for treating an allergic or inflammatory disease
05/31/2005US6899892 Methods to reduce body fat
05/31/2005US6899890 Bioadhesive drug delivery system
05/31/2005US6899888 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899868 Iodine/resin disinfectant and a procedure for the preparation thereof
05/31/2005US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/31/2005US6899723 Transcutaneous photodynamic treatment of targeted cells
05/31/2005US6899700 Therapeutic agent delivery tampon
05/31/2005US6899099 Method for treating a respiratory disease
05/31/2005CA2332929C Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles
05/31/2005CA2324343C C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
05/31/2005CA2216623C Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
05/31/2005CA2158275C Taxanes having an amino substituted side-chain
05/26/2005WO2005047898A2 Methods and compositions for identifying therapeutic compounds
05/26/2005WO2005047548A1 Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
05/26/2005WO2005047524A2 Compositions and methods for inducing cell dedifferentiation
05/26/2005WO2005047504A1 Induction of cellular senescence by cdk4 disruption for tumor suppression and regression
05/26/2005WO2005047475A2 Regulation of cell membrane-mediated effects
05/26/2005WO2005047465A2 Method and antisense compound for potentiating anti-cancer agents
05/26/2005WO2005047366A1 Method of preparing carboxylic acid functionalized polymers
05/26/2005WO2005047321A2 Polynucleotides for inhibition of polypeptide expression and methods of use
05/26/2005WO2005047304A2 Method for obtaining natural products from plant material
05/26/2005WO2005047303A2 NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
05/26/2005WO2005047292A1 Use of thienopyrimidines
05/26/2005WO2005047291A1 Method for the catalytic production of hydrocodone and hydromorphone
05/26/2005WO2005047290A2 Imidazo[1,2-a] pyrazin-8-ylamines as kinase inhibitors
05/26/2005WO2005047289A1 Pyrrolopyrimidine compounds useful in treatment of cancer
05/26/2005WO2005047288A1 Pyrazolopyrimidines as anti - hepatits c agents
05/26/2005WO2005047287A2 Bicyclic pyrazolone cytokine inhibitors
05/26/2005WO2005047286A1 Heterocyclic spiro compound
05/26/2005WO2005047285A1 Substituted naphthyridinone derivatives
05/26/2005WO2005047282A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid
05/26/2005WO2005047278A2 Substituted dihydroquinazolines ii
05/26/2005WO2005047275A1 2-phenyl-benzofuran derivatives, method for the production thereof and their use
05/26/2005WO2005047272A1 Morpholine derivatives as norepinephrine reuptake inhibitors
05/26/2005WO2005047268A2 Substituted pyrimidine compositions and methods of use
05/26/2005WO2005047262A1 Crystalline form of gatifloxacin
05/26/2005WO2005047261A1 Non-hygroscopic crystalline form of gatifloxacin
05/26/2005WO2005047258A2 Methods and compositions for selectin inhibition
05/26/2005WO2005047257A2 Methods and compositions for selectin inhibition
05/26/2005WO2005047256A1 The derivatives of pyridone and the use of them
05/26/2005WO2005047252A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
05/26/2005WO2005047250A1 N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders.
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005WO2005047248A1 4-biarylyl-1-phenylazetidin-2-ones
05/26/2005WO2005047244A2 Inhibition of fgfr3 and treatment of multiple myeloma
05/26/2005WO2005046797A2 Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
05/26/2005WO2005046796A2 Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels
05/26/2005WO2005046746A2 Medical implants and fibrosis-inducing agents
05/26/2005WO2005046727A2 Ibuprofen-containing soft gelatin capsules
05/26/2005WO2005046726A2 Combinations for inhibiting cell growth which contains an inhibitor of human ck1 alpha activity and a rxr agonist
05/26/2005WO2005046725A1 Novel combination containing a stimulator of soluble guanylate cyclase and a lipid-lowering substance
05/26/2005WO2005046724A1 Remedy/preventive for vascular disorders and hypertension and method of screening the same
05/26/2005WO2005046722A2 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
05/26/2005WO2005046720A2 Diagnosis, prognosis and treatment of pulmonary diseases using foxa2
05/26/2005WO2005046711A2 Stimulation or inhibition of gamma delta t-cells to promote or inhibit bone healing
05/26/2005WO2005046708A1 Selective inhibitors of nuclear factor-kb activation and uses thereof
05/26/2005WO2005046706A1 Lipometabolism improver containing pine bark extract
05/26/2005WO2005046702A1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein
05/26/2005WO2005046701A1 Novel methods for administration of drugs and devices useful thereof
05/26/2005WO2005046700A1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
05/26/2005WO2005046699A1 Freeze-dried article containing prostaglandin
05/26/2005WO2005046698A1 Fused heterocyclic compounds
05/26/2005WO2005046697A1 Sustained-release phenylalanine derivative preparation for oral administration
05/26/2005WO2005046696A1 Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative
05/26/2005WO2005046695A1 Injection vitamin b complex for treatment of non specific vaginitis (bacterial vaginitis)
05/26/2005WO2005046694A1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
05/26/2005WO2005046693A1 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
05/26/2005WO2005046692A1 Treatment of genetic diseases with the aid of quinolones, naphthyridones
05/26/2005WO2005046691A1 Combination of a farnesyl tranferase inhibitor with an antihormonal agent for the treatment of breast cancer
05/26/2005WO2005046690A1 Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative
05/26/2005WO2005046689A2 Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity
05/26/2005WO2005046688A2 Methods of use of thrombin receptor antagonists
1 ... 4674 4675 4676 4677 4678 4679 4680 4681 4682 4683 4684 4685 4686 4687 4688 4689 4690 4691 4692 4693 4694 ... 7860